Never mind steering companies through the AI revolution or trade wars. Beating jet lag is equally serious business for globe-trotting corporate bosses. With so much time spent up in the air, they can ...
Vanda Pharmaceuticals (VNDA) lost ~11% in the premarket on Thursday after the U.S. FDA declined to approve a label expansion for its sleep disorder drug Hetlioz (tasimelteon) as a treatment for jet ...
In a saga that has spread over seven years, the FDA has again rejected Vanda’s bid to expand the label for Hetlioz to treat jet lag disorder. The new thumbs-down came Wednesday, three months after the ...
Dec. 29, 2025 – The holidays can be an unexpected litmus test of how well your daily routine syncs – or doesn't – with your body's natural circadian rhythm. You're probably not going to develop social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback